CRISPR gene therapy slashes 'bad' cholesterol, triglycerides
Digest more
MedPage Today on MSN
Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor
N EW ORLEANS -- Innovations in lipid lowering get a major chance to shine, and potentially move the needle in cardiometabolic ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
High cholesterol is a major driver of heart disease. Statins, like Lipitor and Zocor, emerged as powerful antidotes starting ...
With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback